Events

ASLAN Pharmaceuticals announced that an abstract on its lead candidate, varlitinib, has been accepted for poster presentation at the ESMO Asia Congress 2019 in Singapore on 22 November – 24 November.
‘iM-TCRs’ enable controllable cytotoxicity of tumor-specific TCR-T cells to potentially tune safety and efficacy according to clinical needs
Emerald Lake Safety’s Dr. Christina Chow will be co-chairing a symposium on drug safety research in obese patients on Sept. 15 at the 2019 American College of Clinical Pharmacology (ACCP) meetings in Chicago, Illinois.
PharmaMar (MSE:PHM) presented new data on lurbinectedin during the World Conference on Lung Cancer (WCLC), which is taking place from 7th to 10th September in Barcelona.
Amgen announced new data from the ongoing Phase 1 study evaluating AMG 510 in patients with previously treated KRAS G12C-mutated solid tumors.
MaxCyte announces that Director of Field Applications Scientists Christopher Mann, PhD, will present on “Advancing Adoptive Cellular Therapies Using Non-viral-based Engineering” at the 2nd International Conference on Lymphocyte Engineering on Saturday 14 September at 9:50 a.m. BST.
BerGenBio ASA presents study updates from its Phase II clinical development programme with bemcentinib, a first-in-class highly selective oral AXL inhibitor, in non-small cell lung cancer at the 2019 World Conference on Lung Cancer in Barcelona, Spain.
Rho, a full-service contract research organization, is showcasing its nearly 35-year history of success in drug development strategies and services at the Outsourcing in Clinical Trials Texas 2019 Conference, the newest addition to the Outsourcing in Clinical Trials series, taking place September 11-12 in Houston.
Martinsried/ Munich Medigene AG announced its participation at the following upcoming scientific and investor conferences.
Jett Foundation, a non-profit organization dedicated to raising awareness and funds for Duchenne muscular dystrophy, will celebrate World Duchenne Awareness Day (WDAD) on Saturday, September 7.
PRESS RELEASES